Shedding light on DARC: the role of the Duffy antigen/receptor for chemokines in inflammation, infection and malignancy
暂无分享,去创建一个
[1] B. Crabb,et al. Towards a Vaccine against Plasmodium vivax Malaria , 2007, PLoS medicine.
[2] Edward Wright,et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. , 2008, Cell host & microbe.
[3] A. Duits,et al. High Serum Interleukin‐8 Levels in Afro‐Caribbean Women with Pre‐eclampsia. Relations with Tumor Necrosis Factor‐α, Duffy Negative Phenotype and Von Willebrand Factor , 2002, American journal of reproductive immunology.
[4] M. Wadhwa,et al. Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction. , 2000, Transfusion science.
[5] Janet S. Lee,et al. Duffy Antigen Facilitates Movement of Chemokine Across the Endothelium In Vitro and Promotes Neutrophil Transmigration In Vitro and In Vivo1 , 2003, The Journal of Immunology.
[6] J. Dvorak,et al. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. , 1975, Science.
[7] Z. Ou,et al. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential , 2006, Oncogene.
[8] S. Segerer,et al. The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity , 2009, Nature Immunology.
[9] J. Reimund,et al. A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA‐79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146 , 2005, The Journal of pathology.
[10] A. Ashkenazi,et al. Duffy antigen/receptor for chemokines (DARC) attenuates angiogenesis by causing senescence in endothelial cells , 2007, Angiogenesis.
[11] J. Kazura,et al. Expression of Duffy antigen receptor for chemokines during reticulocyte maturation: using a CD71 flow cytometric technique to identify reticulocytes , 2005, Immunohematology.
[12] J. Zagury,et al. Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC). , 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[13] R. Schuster,et al. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] P. Michon,et al. Naturally Acquired and Vaccine-Elicited Antibodies Block Erythrocyte Cytoadherence of the Plasmodium vivaxDuffy Binding Protein , 2000, Infection and Immunity.
[15] R. Horuk,et al. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor , 1995, The Journal of experimental medicine.
[16] A. Lentsch,et al. Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC). , 2000, Blood.
[17] N. Akimitsu,et al. Man, mouse and Duffy genotype–phenotype‐specific pharmacokinetics of monocyte chemotactic protein‐1 , 2004, Transfusion medicine.
[18] M. Joffe,et al. Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function. , 2004, Kidney international.
[19] C. Chitnis,et al. Plasmodium vivax Invasion of Human Erythrocytes Inhibited by Antibodies Directed against the Duffy Binding Protein , 2007, PLoS medicine.
[20] M. Burdick,et al. Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis , 2004, BMC Cancer.
[21] C. Chitnis,et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. , 1993, Science.
[22] L. Gardner,et al. The human Duffy antigen binds selected inflammatory but not homeostatic chemokines. , 2004, Biochemical and biophysical research communications.
[23] G. Meny. The Duffy blood group system: a review , 2010, Immunohematology.
[24] L. Miller,et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. , 1976, The New England journal of medicine.
[25] P. Gane,et al. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism , 1995, Human Genetics.
[26] P. Mollison,et al. The Duffy blood group system , 1950, Heredity.
[27] K. Miura,et al. Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression , 2006, Nature Medicine.
[28] K. Ley,et al. The Duffy antigen receptor for chemokines in acute renal failure: A facilitator of renal chemokine presentation , 2007, Critical care medicine.
[29] R. Strieter,et al. Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. , 2007, Cancer research.
[30] P. Michon,et al. Duffy‐null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood‐stage infection , 2001, FEBS letters.
[31] A. Duits,et al. The association of pre‐eclampsia with the Duffy negative phenotype in women of West African descent , 2002, BJOG : an international journal of obstetrics and gynaecology.
[32] R. Nibbs,et al. Post-translational control of chemokines: a role for decoy receptors? , 2005, Immunology letters.
[33] S. Peiper,et al. From malaria to chemokine receptor: the emerging physiologic role of the Duffy blood group antigen. , 1997, Blood.
[34] C. Tournamille,et al. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy–negative individuals , 1995, Nature Genetics.
[35] C. Buckley,et al. Duffy antigen receptor for chemokines and CXCL5 are essential for the recruitment of neutrophils in a multicellular model of rheumatoid arthritis synovium. , 2008, Arthritis and rheumatism.
[36] Zhaohua Lu,et al. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain , 1996, Journal of leukocyte biology.
[37] E. Akalin,et al. The influence of Duffy blood group on renal allograft outcome in african americans , 2003, Transplantation.